A. Máchalová

Enhancement of psychostimulant effect and development of behavioural sensitisation to methamphetamine in mice by combined treatment with piracetam

K. Šlais, A. Šulcová, A. Máchalová, 2011 .

CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants

O. Hlinomaz, J. Máchal, Z. Splichal, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

Could piracetam potentiate behavioural effects of psychostimulants?

K. Šlais, A. Šulcová, A. Máchalová, 2012, Medical hypotheses.

Interaction of CB1 receptor agonist arachidonylcyclopropylamide with behavioural sensitisation to morphine in mice.

K. Šlais, A. Šulcová, A. Máchalová, 2018 .

Prenatal exposure to modafinil alters locomotor behaviour and leucocyte phagocytosis in mice.

J. Ruda-Kucerova, A. Šulcová, A. Máchalová, 2018, Psychiatria Danubina.

Prenatal exposure to modafinil alters behavioural response to methamphetamine in adult male mice

J. Ruda-Kucerova, A. Šulcová, A. Máchalová, 2018, International Journal of Developmental Neuroscience.

Implication of NMDA receptors in behavioural sensitization to psychostimulants: a short review.

A. Šulcová, A. Máchalová, L. Landa, 2014, European journal of pharmacology.

Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice

K. Šlais, A. Šulcová, A. Máchalová, 2012, Pharmacology Biochemistry and Behavior.

The effect of the cannabinoid CB1 receptor agonist arachidonylcyclopropylamide (ACPA) on behavioural sensitisation to methamphetamine in mice

K. Šlais, A. Šulcová, A. Máchalová, 2018 .